Stilla Technologies

Corning® Matrigel® Matrix for Organoid Culture

Corning Life Sciences

Cubis® II: Your Balance, Your Way

Sartorius Corporation

PerkinElmer Signals™ Screening for HTS, HCS, SPR

PerkinElmer, Inc

Phase I/II Clinical Trial of COVID-19 Vaccine Begins

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, announced enrollment of the first participants in a Phase 1/2 clinical trial of its coronavirus vaccine candidate, NVX‑CoV2373, a stable, prefusion protein made using its proprietary nanoparticle technology.

CytoSMART Technologies Announces Launch of CytoSMART Lux2 Duo Kit

The CytoSMART Lux2 Duo Kit is designed to offer a straightforward, cost-effective solution for researchers carrying out immediate side-by-side comparisons between cell cultures.

SeraNovo and Carna Biosciences Enter Second License Agreement for Development of Oral Formulation of Kinase Inhibitor

Under the agreement, the companies will expand their existing collaboration and jointly develop an oral formulation of a new active ingredient with an enhanced bioavailability.

Tosoh Bioscience Introduces TSKgel® UP-SW Aggregate UHPLC/HPLC Columns

Tosoh Bioscience has announced the introduction of TSKgel UP-SW Aggregate size exclusion chromatography columns.